Lonza Provides New 2024 Targets for Margins, Sales
Lonza Provides New 2024 Targets for Margins, Sales
By Olivia Bugault
作者：奧利維亞·布高
Lonza Group AG gave new midterm financial targets and set its strategic priorities for the coming years as it is hosting its capital-market day on Tuesday.
Lonza Group AG在週二舉辦資本市場日時給出了新的中期財務目標，並設定了未來幾年的戰略優先事項。
The Swiss life-sciences company said that it has updated its 2024 outlook and now expects sales at constant exchange rate to grow in the low teens, while its core earnings before interest, taxes, depreciation and amortization margin should be between approximately 33% and 35%.
這家瑞士生命科學公司表示，它已經更新了2024年的展望，現在預計按固定匯率計算的銷售額將在十幾歲左右增長，而其扣除利息、稅項、折舊和攤銷前的核心收益應在33％至35％之間。
The company also said capital expenditure should reach around 25% of sales this year and will remain high until it returns to the high teens by 2025.
該公司還表示，今年資本支出應達到銷售額的25％左右，並將保持在較高水平，直到2025年恢復到十幾歲的最高水平。
Lonza said that, among its priorities for the years to come, the company will accelerate its derisked investment program to boost sustainable growth.
隆扎說，在未來幾年的優先事項中，該公司將加快其風險投資計劃，以促進可持續增長。
Write to Olivia Bugault at olivia.bugault@wsj.com
通過 olivia.bugault@wsj.com 寫信給 Olivia Bugault
譯文內容由第三人軟體翻譯。